Center Laboratories, Inc.

Taipei Exchange 4123.TWO

Center Laboratories, Inc. Market Capitalization on January 14, 2025: USD 914.21 M

Center Laboratories, Inc. Market Capitalization is USD 914.21 M on January 14, 2025, a -7.67% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Center Laboratories, Inc. 52-week high Market Capitalization is USD 1.23 B on July 08, 2024, which is 34.90% above the current Market Capitalization.
Center Laboratories, Inc. 52-week low Market Capitalization is USD 886.07 M on April 19, 2024, which is -3.08% below the current Market Capitalization.
Center Laboratories, Inc. average Market Capitalization for the last 52 weeks is USD 1.01 B.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Taipei Exchange: 4123.TWO

Center Laboratories, Inc.

CEO	Ms. Su-Chi Wang
IPO Date	Dec. 31, 2007
Location	Taiwan
Headquarters	No. 3-2, Yuanyuan Street
Employees	182
Sector	Health Care
Industries Pharmaceuticals

Description

Center Laboratories, Inc. engages in the manufacture and trading of various medicines in Taiwan. It engages in the research and development of small molecule drugs; manufacture and sale of pharmaceuticals; development of proteins and antibodies; and pharmaceutical CDMO, medical device, nutritional health and agribiotechnology, stem cell and immune cell therapy, and industry investment fund and venture capital businesses. The company was founded in 1959 and is headquartered in Taipei, Taiwan.

Key trends

Past 5 years